Supplemental material
Future Oncology
Volume 20, 2024 - Issue 9
Open access
607
Views
0
CrossRef citations to date
0
Altmetric
Short Communication
Effectiveness and Safety of Anticoagulants Among Patients with Venous Thromboembolism and Common Cancers or Cancers with High Venous Thromboembolism Risk
Alexander T Cohen1 Department of Hematological Medicine, Guy’s & St Thomas’ NHS Foundation Trust, King’s College London, Westminster Bridge Road, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-9398-4621
Virginia Noxon2 STATinMED, LLC, Dallas, TX75240, USA
https://orcid.org/0000-0002-6411-8652
Amol D Dhamane3 Bristol Myers Squibb Company, Lawrenceville, NJ08648, USA
, Shrushti Shah2 STATinMED, LLC, Dallas, TX75240, USA
, Dionne M Hines4 Pfizer Inc., New York, NY10017, USA
, Tamuno Alfred4 Pfizer Inc., New York, NY10017, USA
& Xuemei Luo5 Pfizer Inc., Groton, CT06340, USA
show all
Pages 521-532
|
Received 13 Dec 2022, Accepted 15 Nov 2023, Published online: 10 Jan 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.